Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 2 May 2021
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 2 May 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of BXPHARMA) the organic growth of business and hence the profit, part of this attributable to the income from Vaccine distribution and increased cash incentive from export. They also informed that they have entered into a tripartite agreement with the Government of Bangladesh (GOB) and the Serum Institute of India Pvt. Ltd. (SII), for the supply of 30 million doses of Oxford University-AstraZenca SARS-CoV-2 vaccine, AZD1222, in Bangladesh. The Company (Cont-2)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b000040053b03
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.